Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stephanie Pepin
Epidemiology and Burden of Influenza in Healthy Children Aged 6 to 35 Months: Analysis of Data From the Placebo Arm of a Phase III Efficacy Trial
BMC Infectious Diseases
Infectious Diseases
Related publications
Clinical Presentation of Influenza in Children 6 to 35 Months of Age
Pediatric Infectious Disease Journal
Child Health
Infectious Diseases
Pediatrics
Perinatology
Microbiology
Oral Prednisolone in the Acute Management of Children Age 6 to 35 Months With Viral Respiratory Infection-Induced Lower Airway Disease: A Randomized, Placebo-Controlled Trial
Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Validation and Evaluation of Serological Correlates of Protection for Inactivated Enterovirus 71 Vaccine in Children Aged 6-35 Months
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Burden of HIV Infection Among Children Aged 18 Months to 14 Years in Kenya
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Lessons From the First Year of the WAIVE Study Investigating the Protective Effect of Influenza Vaccine Against Laboratory-Confirmed Influenza in Hospitalised Children Aged 6-59 Months
Influenza and other Respiratory Viruses
Environmental
Public Health
Epidemiology
Pulmonary
Infectious Diseases
Respiratory Medicine
Occupational Health
Etiology of Anemia in Children Aged Between 6 Months and 18 Years
Journal of Surgery and Medicine
Efficacy and Safety of Velmanase Alfa in the Treatment of Patients With Alpha-Mannosidosis: Results From the Core and Extension Phase Analysis of a Phase III Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
Journal of Inherited Metabolic Disease
Genetics
Epidemiology of Allergic Diseases of Hungarian Children Aged 6 and 14 Years
Pediatric Research
Child Health
Pediatrics
Perinatology
Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink
Archives of Pediatrics & Adolescent Medicine
